Target intelligence / Profile preview

Adipocyte-associated metabolic related long non-coding RNA 1 (ASMER1)

Target
ASMER1
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein coding RNA)
01

Overview

Adipocyte-associated metabolic related lncRNA 1 (ASMER1) is a long non-coding RNA highly enriched in human adipocytes and regulated by metabolic and inflammatory states. ASMER1 is conserved at the exon level and distributed in both nuclear and cytoplasmic compartments of adipocytes[3]. Functional studies using antisense oligonucleotide-mediated knockdown demonstrate that ASMER1 is required for normal adipogenesis, adiponectin secretion, and lipid mobilization. Expression of ASMER1 is upregulated in adipose tissue from obese humans and mice, signifying its role in obesity pathophysiology[1][3]. Loss of ASMER1 function adversely affects fat cell differentiation and metabolic functions, indicating its potential as a novel therapeutic target for metabolic diseases. At present, no drugs are listed as directly interacting with ASMER1, but its modulation is feasible by genetic or RNA-targeted approaches.

Other names
ASMER-1ENST00000418954Adipocyte-specific metabolic related lncRNA 1LINC02246Long intergenic non-protein coding RNA 2246ASMER1
02

Mechanism of action

Antisense oligonucleotides targeting ASMER1 suppress adipogenesis, adiponectin production, and lipid mobilization; experimental knockdown reveals direct impact on fat precursor cell differentiation and mature adipocyte function[3][1].

03

Biological functions

Regulation of adipogenesis (formation of adipocytes)Control of adiponectin secretionRegulation of lipid mobilizationPartial influence over transcriptional networks in fat cells
04

Disease associations

ObesityInsulin resistanceOther metabolic diseases linked to adipose tissue dysfunction
05

Safety considerations

No direct safety concerns reported for ASMER1 targeting, but modulation of adipogenesis and adipocyte function could potentially influence whole-body metabolic homeostasis
06

Biomarkers

ASMER1 expression levels (potential biomarker for adipocyte function and obesity-associated metabolic profiles)

Beyond the preview

Go deeper on Adipocyte-associated metabolic related long non-coding RNA 1 (ASMER1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipocyte-associated metabolic related long non-coding RNA 1 (ASMER1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call